Lionheart Acquisition Co. II (LCAP) Competitors

Minerva Neurosciences (NASDAQ:NERV) and Lionheart Acquisition Co. II (NASDAQ:LCAP) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, earnings, profitability, media sentiment, valuation, risk and community ranking.

Which has more volatility & risk, NERV or LCAP?

Minerva Neurosciences has a beta of 0.21, meaning that its share price is 79% less volatile than the S&P 500. Comparatively, Lionheart Acquisition Co. II has a beta of 0.08, meaning that its share price is 92% less volatile than the S&P 500.

Does the MarketBeat Community favor NERV or LCAP?

Minerva Neurosciences received 347 more outperform votes than Lionheart Acquisition Co. II when rated by MarketBeat users.

Company	Underperform	Outperform
Minerva Neurosciences	Outperform Votes 347 60.98%	Underperform Votes 222 39.02%
Lionheart Acquisition Co. II	N/A	N/A

Which has stronger earnings & valuation, NERV or LCAP?

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Minerva Neurosciences	N/A	N/A	-$30M	-$4.65	-0.54
Lionheart Acquisition Co. II	N/A	N/A	$3.21M	N/A	N/A

Do analysts prefer NERV or LCAP?

Minerva Neurosciences presently has a consensus price target of $11.00, suggesting a potential upside of 338.25%. Given Lionheart Acquisition Co. II's higher probable upside, analysts clearly believe Minerva Neurosciences is more favorable than Lionheart Acquisition Co. II.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Minerva Neurosciences	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Lionheart Acquisition Co. II	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Does the media prefer NERV or LCAP?

In the previous week, Minerva Neurosciences had 1 more articles in the media than Lionheart Acquisition Co. II. MarketBeat recorded 1 mentions for Minerva Neurosciences and 0 mentions for Lionheart Acquisition Co. II. Lionheart Acquisition Co. II's average media sentiment score of 0.67 beat Minerva Neurosciences' score of 0.00 indicating that Minerva Neurosciences is being referred to more favorably in the media.

Company	Overall Sentiment
Minerva Neurosciences	Positive
Lionheart Acquisition Co. II	Neutral

Is NERV or LCAP more profitable?

Lionheart Acquisition Co. II's return on equity of 0.00% beat Minerva Neurosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Minerva Neurosciences	N/A	N/A	-50.27%
Lionheart Acquisition Co. II	N/A	-44.30%	1.39%

Do insiders & institutionals believe in NERV or LCAP?

34.6% of Minerva Neurosciences shares are owned by institutional investors. 6.4% of Minerva Neurosciences shares are owned by company insiders. Comparatively, 19.4% of Lionheart Acquisition Co. II shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

Minerva Neurosciences beats Lionheart Acquisition Co. II on 7 of the 10 factors compared between the two stocks.